The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter

Molecular and Cellular Biology

Volumn 17, Issue 1, 1997, Pages 100-114

  Facchini, Linda M ^a,b   Chen, Shaojun ^b   Marhin, Wilson W ^a,b   Lear, Justin N ^a,b   Penn, Linda Z ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE ZIPPER PROTEIN; LUCIFERASE; MUTANT PROTEIN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CIS TRANS ISOMERISM; CONTROLLED STUDY; DIMERIZATION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 0031036152     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.1.100     Document Type: Article

References (114)

1. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.
2. Alexander, W. S., J. M. Adams, and S. Cory. 1989. Oncogene cooperation in lymphocyte transformation: malignant conversion of Eμ-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Mol. Cell. Biol. 9:67-73.
3. Alexandrova, N., J. Niklinski, V. Bliskovsky, G. A. Otterson, M. Blake, F. J. Kaye, and M. Zajac-Kaye. 1995. The N-terminal domain of c-Myc associates with α-tubulin and microtubules in vivo and in vitro. Mol. Cell. Biol. 15:5188-5195.
4. Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
5. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast. Nature 359:423-426.
6. Amati, B., T. D. Littlewood, G. I. Evan, and H. Land. 1993. The c-Myc protein induces cell cycle progression and apoptosis. EMBO J. 12:5083-5087.
7. Asselin, C., A. Nepveu, and K. B. Marcu. 1989. Molecular requirements for transcriptional initiation of the murine c-myc gene. Oncogene 4:549-558.
8. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
9. Beijersbergen, R. L., E. M. Hijmans, L. Zhu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080-4086.
10. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcription target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
11. Bentley, D. L., and M. Groudine. 1986. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702-706.
12. Bentley, D. L., and M. Groudine. 1988. Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53:245-256.
13. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513-2523.
14. Berry, M., D. Metzger, and P. Chambon. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811-2818.
15. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence specific DNA binding by the c-Myc protein. Science 250:1149-1152.
16. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251:1211-1217.
17. Blackwood, E. M., B. Lüscher, and R. M. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71-80.
18. Bodrug, S. E., B. J. Warner, M. L. Bath, G. J. Lindeman, A. W. Harris, and J. M. Adams. 1994. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13: 2124-2130.
19. Bossone, S. A., C. Asselin, A. J. Patel, and K. B. Marcu. 1992. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc. Natl. Acad. Sci. USA 89:7452-7456.
20. Buckle, R. S., and M. Mechali. 1995. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism. Oncogene 10:1249-1255.
21. Catron, K. M., H. Zhang, S. C. Marshall, J. A. Inostroza, J. M. Wilson, and C. Abate. 1995. Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol. Cell. Biol. 15:861-871.
22. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
23. Chung, J., E. Sinn, R. R. Reed, and P. Leder. 1986. Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 83:7918-7922.
24. Cleveland, J. L., M. Huleihel, P. Bressler, U. Siebenlist, L. Akiyama, R. N. Eisenman, and U. R. Rapp. 1988. Negative regulation of c-myc transcription involves myc family proteins. Oncogene Res. 3:357-375.
25. Dagnino, L., L. Zhu, K. L. Skorecki, and H. L. Moses. 1995. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins. Cell Growth Differ. 6:191-198.
26. Daksis, J. I., R. Y. Lu, L. M. Facchini, W. W. Marhin, and L. J. Z. Penn. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635-3645.
27. Danielian, P. S., R. White, S. A. Hoare, S. E. Fawell, and M. G. Parker. 1993. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol. 7:232-240.
28. Dean, M., R. A. Levine, W. Ran, M. S. Kindy, G. E. Sonenshein, and J. Campisi. 1986. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem. 261:9161-9166.
29. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.
30. Du, H., A. L. Roy, and R. G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501-511.
31. Dufort, D., M. Drolet, and A. Nepveu. 1993. A protein binding site from the murine c-myc promoter contributes to transcriptional block. Oncogene 8:165-171.
32. Dufort, D., and A. Nepveu. 1994. The human Cut homeodomain protein represses transcription from the c-myc promoter. Mol. Cell. Biol. 14:4251-4257.
33. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras between Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68.
34. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The myc protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
35. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
36. Facchini, L. M., S. Chen, and L. J. Z. Penn. 1994. Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line. Cell Growth Differ. 5:637-646.
37. Facchini, L. M., and L. Z. Penn. Unpublished data.
38. Fisher, F., D. H. Crouch, P.-S. Jayaraman, W. Clark, D. A. F. Gillespie, and C. R. Goding. 1993. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J. 12:5075-5082.
39. Freytag, S. O., C. V. Dang, and W. M. F. Lee. 1990. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1:339-343.
40. Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers. 1995. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14:1508-1519.
41. Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
42. Grignani, F., L. Lombardi, I. Giorgio, L. Sternas, K. Cechova, and R. Dalla-Favera. 1990. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 9:3913-3922.
43. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-254.
44. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935-2939.
45. Hall, D. J. 1990. Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1. Oncogene 5:47-54.
46. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431-3438.
47. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
48. Harada, R., G. Bérubé, O. J. Tamplin, C. Denis-Larose, and A. Nepveu. 1995. DNA-binding specificity of the Cut repeats from the human Cut-like protein. Mol. Cell. Biol. 15:129-140.
49. Hiebert, S. W., M. Lipp, and J. R. Nevins. 1989. E1A-dependent transaetivation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA 86:3594-3598.
50. Inghirami, G., F. Grignani, L. Sternas, L. Lombardi, D. M. Knowles, and R. Dalla-Favera. 1990. Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science 250:682-686.
51. Kato, G. J., W. M. F. Lee, L. Chan, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
52. Kelly, K., B. Cochran, C. Stiles, and P. Leder. 1983. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
53. Kelly, K., and U. Siebenlist. 1986. The regulation and expression of c-myc in normal and malignant cells. Annu. Rev. Immunol. 4:317-338.
54. Kingston, R. E., C. A. Bunker, and A. N. Imbalzano. 1996. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 10:905-920.
55. Kitaura, H., I. Galli, T. Taira, S. M. Iguchi-Ariga, and H. Ariga. 1991. Activation of c-myc promoter by c-myc protein in serum starved cells. FEBS Lett. 290:147-152.
56. Krumm, A., L. B. Hickey, and M. Groudine. 1995. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev. 9:559-572.
57. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
58. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
59. Li, L.-H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070-4079.
60. Lipp, M., R. Schilling, S. Wiest, G. Laux, and G. W. Bornkamm. 1987. Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene. Mol. Cell. Biol. 7:1393-1400.
61. Littlewood, T. D., B. Amati, H. Land, and G. I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7:1783-1792.
62. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
63. Lucas, J. M., N. M. Wilkie, and J. C. Lang. 1993. c-MYC repression of promoter activity through core promoter elements. Biochem. Biophys. Res. Commun. 194:1446-1452.
64. Lüscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb. Part I. Myc. Genes Dev. 4:2025-2035.
65. Maheswaran, S., H. Lee, and G. E. Sonenshein. 1994. Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol. Cell. Biol. 14:1147-1152.
66. Mai, S., and I. L. Martensson. 1995. The c-myc protein represses the lambda 5 and TdT initiators. Nucleic Acids Res. 23:1-9.
67. Mann, R., R. C. Mulligan, and D. Baltimore. 1983. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159.
68. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
69. Marhin, W. W., Y.-J. Hei, S. Chen, Z. Jiang, B. Gallie, R. A. Philips, and L. Z. Penn. 1996. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. Oncogene 12:43-52.
70. Marhin, W., and L. Z. Penn. Unpublished data.
71. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
72. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
73. Moberg, K. H., W. A. Tyndall, J. Pyrc, and D. J. Hall. 1991. Analysis of the c-myc P2 promoter. J. Cell. Physiol. 148:75-84.
74. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
75. Mukherjee, B., S. D. Morgenbesser, and R. A. DePinho. 1992. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6:1480-1492.
76. Nepveu, A., and K. B. Marcu. 1986. Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J. 5:2859-2865.
77. Penn, L. J. Z., M. W. Brooks, E. M. Laufer, and H. Land. 1990. Negative autoregulation of c-myc transcription. EMBO J. 9:1113-1121.
78. Penn, L. J. Z., M. W. Brooks, E. M. Laufer, T. D. Littlewood, J. P. Morgenstern, G. I. Evan, W. M. F. Lee, and H. Land. 1990. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol. Cell. Biol. 10:4961-4966.
79. Penn, L. J. Z., E. M. Laufer, and H. Land. 1990. C-MYC: Evidence for multiple regulatory functions. Sem. Cancer Biol. 1:69-80.
80. Philipp, A., A. Schneider, I. Väsrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of Myc. Mol. Cell. Biol. 14:4032-4043.
81. Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65:395-407.
82. Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specifie DNA binding by the c-Myc basic region. Science 251:186-189.
83. Rabbitts, P. H., J. V. Watson, A. Lamond, A. Forster, M. A. Stinson, G. Evan, W. Fischer, et al. 1985. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009-2015.
84. Ragimov, N., A. Krauskopf, N. Navot, V. Rotter, M. Oren, and Y. Aloni. 1993. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 8:1183-1193.
85. Ray, R., and D. M. Miller. 1991. Cloning and characterization of a human c-myc promoter-binding protein. Mol. Cell. Biol. 11:2154-2161.
86. Ray, R. B. 1995. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ. 6:1089-1096.
87. Ray, R. B., R. Steele, E. Seftor, and M. Hendrix. 1995. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res. 55: 3747-3751.
88. Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57-65.
89. Riggs, K. J., S. Saleque, K.-K. Wong, K. T. Merrell, J.-S. Lee, Y. Shi, and K. Calame. 1993. Yin-yang 1 activates the c-myc promoter. Mol. Cell. Biol. 13:7487-7495.
90. Rosenbaum, H., A. W. Harris, M. L. Bath, J. McNeall, E. Webb, J. M. Adams, and S. Cory. 1990. An E μ-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J. 9:897-905.
91. Roussel, M. F., J. N. Davis, J. L. Cleveland, J. Ghysdael, and S. W. Hiebert. 1994. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9:405-415.
92. Roy, A. L., C. Carruthers, T. Gutjahr, and R. G. Roeder. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365:359-361.
93. Saito, H., A. C. Hayday, K. Wiman, W. S. Hayward, and S. Tonegawa. 1983. Activation of the c-myc gene by translocation: a model for translational control. Proc. Natl. Acad. Sci. USA 80:7476-7480.
94. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxil mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
95. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
96. Shrivastava, A., S. Saleque, G. V. Kalpana, S. Artandi, S. P. Goff, and K. Calame. 1993. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889-1892.
97. Solomon, D. L., A. Philipp, H. Land, and M. Eilers. 1995. Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene 11:1893-1897.
98. Spencer, C. A., and M. Groudine. 1991. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1-48.
99. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
100. Suen, T.-C., and M.-C. Hung. 1991. c-myc reverses neu-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11:354-362.
101. Takimoto, M., J. P. Quinn, A. R. Farina, L. M. Staudt, and D. Levens. 1989. fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J. Biol. Chem. 264:8992-8999.
102. Thalmeier, K., H. Synovzik, R. Mertz, E. L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev. 3:527-536.
103. Thompson, J. F., L. S. Hayes, and D. B. Lloyd. 1991. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 103:171-177.
104. Tikhonenko, A. T., D. J. Black, and M. L. Linial. 1995. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype. Oncogene 11:1499-1508.
105. Versteeg, R., I. A. Noordermeer, M. Kruse-Wolters, D. J. Ruiter, and P. I. Schrier. 1988. c-myc down-regulates class I HLA expression in human melanomas. EMBO J. 7:1023-1029.
106. Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. C-myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
107. Watanabe, S., S. Ishida, K. Koike, and K. Arai. 1995. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor. Mol. Biol. Cell 6:627-636.
108. Waters, C. M., T. D. Littlewood, D. C. Hancock, J. P. Moore, and G. I. Evan. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6:797-805.
109. Webster, N. J., S. Green, J. R. Jin, and P. Chambon. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199-207.
110. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
111. Wenzel, A., C. Czieptuch, U. Hamann, J. Schurmann, and M. Schwab. 1991. The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO J. 10:3703-3712.
112. Wong, K.-K., X. Zou, K. T. Merrell, A. J. Patel, K. B. Marcu, S. Chellappan, and K. Calame. 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15:6535-6544.
113. Yang, B.-S., J. D. Gilbert, and S. O. Freytag. 1993. Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol. Cell. Biol. 13:3093-3102.
114. Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.